NCT05553197

Brief Summary

The effects of a monitoring intervention as an add-on to face-to-face Cognitive Behavioral Therapy (CBT) for depression are assessed in this randomised trial. Monitoring consists of Ecological Momentary Assessment (EMA) of symptoms and inter-session processes via mobile phones. Twenty sessions of face-to-face CBT + EMA are compared to twenty sessions of face-to-face CBT (treatment as usual, TAU). 84 patients with mild to moderate depression will be randomised to CBT + EMA or to TAU.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
1mo left

Started Nov 2022

Longer than P75 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Nov 2022May 2026

First Submitted

Initial submission to the registry

August 18, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 23, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Last Updated

June 25, 2025

Status Verified

June 1, 2025

Enrollment Period

3.6 years

First QC Date

August 18, 2022

Last Update Submit

June 18, 2025

Conditions

Keywords

DepressionPsychotherapyMonitoringRandomised Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Patient Health Questionnaire (PHQ-9)

    Participant-reported measure assessing depressive symptomatology. The total score of this nine-item scale ranges from 0-27, with higher scores indicating greater depression-symptom severity.

    4-month follow-up

Secondary Outcomes (12)

  • Patient Health Questionnaire (PHQ-9)

    Baseline, 4 weeks after the 4th session, 4 weeks after the 12th session, immediately after the last session and the 4-month follow-up

  • Beck's Depression Inventory (BDI-II)

    Baseline, 4 weeks after the 4th session, 4 weeks after the 12th session, immediately after the last session and the 4-month follow-up

  • Certainty About Mental States Questionnaire (CAMSQ)

    Baseline, 4 weeks after the 4th session, 4 weeks after the 12th session, immediately after the last session and the 4-month follow-up

  • Dysfunctional Attitude Scale (DAS-18A)

    Baseline, 4 weeks after the 4th session, 4 weeks after the 12th session, immediately after the last session and the 4-month follow-up

  • Depression-Specific Self-Efficacy Expectation Questionnaire (DSWE)

    Baseline, 4 weeks after the 4th session, 4 weeks after the 12th session, immediately after the last session and the 4-month follow-up

  • +7 more secondary outcomes

Study Arms (2)

Cognitive Behavior Therapy + Ecological Momentary Assessment (CBT + EMA)

EXPERIMENTAL

Cognitive Behavior Therapy + Ecological Momentary Assessment

Behavioral: Cognitive Behavioural Therapy (CBT)Other: Ecological Momentary Assessment (EMA)

Treatment as Usual (TAU)

ACTIVE COMPARATOR

Cognitive Behavioural Therapy (Treatment as Usual)

Behavioral: Cognitive Behavioural Therapy (CBT)

Interventions

20 sessions of face-to-face, individual CBT

Cognitive Behavior Therapy + Ecological Momentary Assessment (CBT + EMA)Treatment as Usual (TAU)

Two four-week blocks of twice daily ecological momentary assessment (EMA) of symptoms and inter-session processes

Cognitive Behavior Therapy + Ecological Momentary Assessment (CBT + EMA)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ICD-10 diagnosis of mild or moderate depression, first or recurrent episode (F32.0, F32.1, F33.0, F33.1)
  • PHQ-9 ≥ 5
  • Possession of smartphone with internet access
  • Signed informed consent

You may not qualify if:

  • Acute or past suicidality; self-reported
  • Acute addiction (F10 - F19)
  • Dysthymia (F34.1), postpartum depression, or severe depression (F32.3; F33.3)
  • PHQ-9 \> 20
  • Depression not main mental health concern
  • Planned onset or planned change in antidepressant medication
  • History of psychotic symptoms, bipolar disorder, personality disorders, or organic brain disorders
  • Cognitive impairment or physical disability that would hinder psychotherapy or the use of a smartphone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Psychotherapeutisches Zentrum Universität Zürich

Zurich, Canton of Zurich, 8032, Switzerland

RECRUITING

MeSH Terms

Conditions

Depression

Interventions

Cognitive Behavioral TherapyEcological Momentary Assessment

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesPsychological Tests

Study Officials

  • Birgit Watzke, PhD

    University of Zurich

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
As is common in psychotherapy research, participants and care providers cannot be blinded to the intervention. Only subjective outcomes (i.e., participant-rated) are assessed.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 4/7 of participants will be randomised to CBT + EMA and 3/7 to TAU. This randomisation ratio is chosen to foster longitudinal analyses in the CBT + EMA group. Randomisation is stratified by pre-treatment severity of depressive symptoms. Participants with PHQ-9 scores 5-9 will be randomised separately from participants with PHQ-9 scores 10-20.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

August 18, 2022

First Posted

September 23, 2022

Study Start

November 1, 2022

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

May 31, 2026

Last Updated

June 25, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations